NEW YORK (360Dx) – Ortho Clinical Diagnostics said today that it has entered an agreement with Sentinel Diagnostics for distribution and promotion of Sentinel's CRP Ultra (MP) wide-range C-reactive protein assay.

Ortho said that it will initially launch the assay, an immuno-turbidimetric test that measures CRP in serum or plasma, in North America, Europe, Africa, and the Middle East.

Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.